Lucintel Report Outlines $100 Billion Market for Global Oncology Drugs Industry in 2018


   January 1 2013

The global oncology drugs industry experienced significant growth during the past five years and is expected to continue that momentum to reach an estimated $100.6 billion in 2018.



Lucintel, a leading global Management Consulting and market research firm, has analyzed the global oncology drugs industry and presents its findings in “Global Oncology Drugs Industry 2013-2018: Trend, Profit, and Forecast Analysis.” The industry comprises firms primarily engaged in the development, manufacture, and marketing of oncology drugs.



Lucintel’s study of the oncology drugs industry includes all classes of drugs that are used as an anti-cancer drug for the treatment of cancer such as lung cancer, mouth cancer, colorectal cancer, skin cancer, kidney cancer, and all such other types of cancer, which are marketed and distributed as an oncology drugs.



North America dominates this industry with more than one-third of the market share. Roche Holding Ltd., Novartis AG, Astra Zeneca Plc, Eli Lilly & Co., and Sanofi SA are the major industry players. A combination of factors such as technology innovations, medical insurance coverage, aging population, and changing lifestyles are seen to affect market dynamics significantly. The industry has seen a number of recent changes including growing competition, rise in merger and acquisition activities, increased cancer health insurance coverage, and an increasing amount of foreign direct investment.



As per the study, aging population, changing lifestyles, more effective diagnosing, unhealthy eating habits, and an increasing incidence of chronic diseases across the entire global population will provide growth opportunities for the oncology drugs industry players.

This study provides an overview of the global oncology drugs industry and tracks industry performance in four geographic regions. The report studies manufacturers and distributors of oncology drugs, providing a five-year annual trend analysis that highlights market size, profit and cost structure for North America, Europe, Asia Pacific (APAC), and the Rest of the World (ROW). The report also provides a forecast, addressing market opportunities for next five years for each of these regions.



For a detailed table of contents and pricing information on this timely, insightful report, contact Lucintel at +1-972-636-5056 or via email at helpdesk@lucintel.com. Lucintel provides cutting-edge decision support services that facilitate critical decisions with greater speed, insight, and cost efficiency. To learn more, visit www.lucintel.com.

Lucintel Corporate Customers

Market Entry, M & A, Opportunity Screening,...

Private Equity Customers

Buy Side Services (target screening, due diligence, ..)

Market Research Reports

Aerospace & Defense [44]
Chemical [100]
Composites & Advanced Materials [99]
Construction & Industrial [40]
Consumer and Retail [78]
Economic Analysis [86]
Energy & Utility [68]
Finance & Services [10]
Healthcare [23]
Media & Entertainment [16]
Metals & Mining [16]
Technology & Telecommunication [44]
Transportation [75]

Customer Quotes

"With more than 20 years experience in the industry, this is the first time we have come across such an extensive market analysis for our industry." Ven Cote, CEO, ZCL

"The insights we gained from Lucintel work helped with our business plan…a wonderful professional job…" Mike Jackson, Stahlin

"The report from Lucintel is useful not only for business planners, but also for the technology officers wanting to create a roadmap …" Dr. Giulio Ranzo, Booz Allen

"The information is so comprehensive, it has allowed us to identify & focus our business development efforts. It saved months of leg-work." Bill Barz, L&L Products

"We bought Lucintel report because it is the best report about our industry…a complete and appropriate analysis." Cesare Andrenacci, Ferretti

Quick Query

Partnership between Jushi USA and Gray Construction ...
Armor Express Awarded Five-Year ID/IQ Hard Armor Contract from U.S. Customs and Border Protection...
Hyundai Files Patent for CFRP Front End...
Velocity Composites Signs Long Term Agreement ...
Johns Manville's Starrov 853 for LFT Reinforcements is Available in Americas and Europe ...

Follow us on